Skip to content
New: free dose calculator with 14 peptide presets. No signup.
Peptides Academy
Human Insulin (Regular / NPH)
Growth Factor

Human Insulin (Regular / NPH)

Humulin / Novolin

Insulin is the hormone the pancreas releases after eating to move glucose out of the bloodstream and into cells for energy and storage. It is a small protein of 51 amino acids arranged as two chains — an A-chain of 21 residues and a B-chain of 30 — held together by disulfide bridges. Discovered in 1921–22, purified from animal pancreas for decades, and since the 1980s produced as recombinant "human" insulin (an exact copy of the human sequence made in bacteria or yeast), insulin is one of medicine's most important and life-saving drugs and a WHO Essential Medicine. Human insulin is supplied in two classic forms distinguished by how fast and how long they act. Regular (soluble) insulin is short-acting: injected under the skin it begins working in about 30 minutes and covers a meal over several hours, and it is the form given intravenously in hospitals for emergencies such as diabetic ketoacidosis. NPH (isophane) insulin is intermediate-acting: it is Regular insulin complexed with protamine so it forms a cloudy suspension that dissolves slowly, giving a longer, peaked action used as a basal (background) insulin. Many people combine the two, and premixed formulations exist. Modern rapid-acting and long-acting analog insulins (lispro, aspart, glargine, degludec and others) were engineered to improve on human insulin's timing, but Regular and NPH remain widely used worldwide, are far less expensive, and are entirely adequate for many patients. All insulins share the same fundamental risk — hypoglycemia (blood sugar too low) — and require dose matching to food, activity, and glucose monitoring. Insulin is a prescription hormone used under medical guidance in type 1 diabetes (where it is essential to life), in many people with type 2 diabetes, and in other conditions; it is not a performance or wellness product, and dosing errors can be dangerous.

Specifications

Dose RangeU-100 standard (U-500 concentrated Regular exists)
Origin / ManufacturerRecombinant human sequence (E. coli or yeast)
Regulatory Status
FDA-approvedEMA-approvedWHO Essential Medicine
Active Components
Human insulin (rDNA origin)
StorageRefrigerate unopened; in-use vials/pens per label
Form FactorSubcutaneous injection (vial/pen); Regular also IV

Frequently Asked Questions

Reviewed by

Clinical Research Review Board

Pharmacology & Endocrinology Review

All clinical claims cross-checked against primary sources. Read our editorial policy →

Related Peptides

Glucagon
growth factor

Glucagon

GlucaGen / Baqsimi / Gvoke

Insulin's counter-regulatory partner: a 29–amino-acid pancreatic hormone that raises blood glucose by mobilizing the liver's stored sugar. As a medicine it is the emergency rescue treatment for severe hypoglycemia.

Fixed rescue doses (kit/nasal/autoinjector)FDA-approvedEMA-approvedWHO Essential Medicine
Insulin Aspart
growth factor

Insulin Aspart

NovoLog / NovoRapid / Fiasp

A rapid-acting analog insulin: replacing one B-chain amino acid with aspartic acid reduces self-clumping for fast mealtime action. An ultra-rapid version (Fiasp) is absorbed even more quickly.

U-100FDA-approvedEMA-approved
Insulin Degludec
growth factor

Insulin Degludec

Tresiba

An ultra-long-acting basal insulin: a fatty-acid tail makes it form long chains of multihexamers under the skin that release insulin very slowly, giving an exceptionally flat profile lasting well beyond 24 hours with flexible dosing timing.

U-100 and U-200FDA-approvedEMA-approved
Insulin Glargine
growth factor

Insulin Glargine

Lantus / Toujeo / Basaglar

A long-acting basal analog insulin engineered to precipitate under the skin and release slowly, giving roughly 24-hour, relatively flat background glucose coverage from a once-daily injection.

U-100 (Lantus/Basaglar); U-300 (Toujeo)FDA-approvedEMA-approved
Insulin Lispro
growth factor

Insulin Lispro

Humalog / Admelog / Lyumjev

A rapid-acting analog insulin: swapping two B-chain amino acids stops the molecules from clumping, so it is absorbed and acts faster than human Regular insulin — designed to be taken right at mealtimes.

U-100 (U-200 pen available)FDA-approvedEMA-approved
Reviewed by Clinical Research Review BoardPharmacology & Endocrinology Review

Search

Search across products, blog posts, wiki articles, and more.